The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Nicotinamide mononucleotide requires SIRT3 to improve cardiac function and bioenergetics in a Friedreich’s ataxia cardiomyopathy model
Open accessAbstract
Increasing NAD + levels by supplementing with the precursor nicotinamide mononucleotide (NMN) improves cardiac function in multiple mouse models of disease. While NMN influences several aspects of mitochondrial metabolism, the molecular mechanisms by which increased NAD + enhances cardiac function are poorly understood. A putative mechanism of NAD + therapeutic action exists via activation of the mitochondrial NAD + -dependent protein deacetylase sirtuin 3 (SIRT3). We assessed the therapeutic efficacy of NMN and the role of SIRT3 in the Friedreich’s ataxia cardiomyopathy mouse model (FXN-KO). At baseline, the FXN-KO heart has mitochondrial protein hyperacetylation, reduced Sirt3 mRNA expression, and evidence of increased NAD + salvage. Remarkably, NMN administered to FXN-KO mice restores cardiac function to near-normal levels. To determine whether SIRT3 is required for NMN therapeutic efficacy, we generated SIRT3-KO and SIRT3-KO/FXN-KO (double KO [dKO]) models. The improvement in cardiac function upon NMN treatment in the FXN-KO is lost in the dKO model, demonstrating that the effects of NMN are dependent upon cardiac SIRT3. Coupled with cardio-protection, SIRT3 mediates NMN-induced improvements in both cardiac and extracardiac metabolic function and energy metabolism. Taken together, these results serve as important preclinical data for NMN supplementation or SIRT3 activator therapy in Friedreich’s ataxia patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“SIRT3 mediates NMN-induced improvements in cardiac and extracardiac metabolic function in a mouse model of cardiomyopathy207.”
From NAD+ metabolism and its roles in cellular processes during ageing (2021) · cites this paper as [207]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bioconductor: open software development for computational biology and bioinformatics
Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 12,082
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
affy—analysis of Affymetrix GeneChip data at the probe level
Gautier, L., Cope, L., Bolstad, B. M., & Irizarry, R. A. (2004) · Bioinformatics · doi:10.1093/bioinformatics/btg405 · Cited by 5,221
A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis
Ahn, B.-H., Kim, H.-S., Song, S., Lee, I. H., Liu, J., Vassilopoulos, A., Deng, C.-X., & Finkel, T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803790105 · Cited by 1,291
Self-citationCantó, C., Houtkooper, R. H., Pirinen, E., Youn, D. Y., Oosterveer, M. H., Cen, Y., Fernandez-Marcos, P. J., Yamamoto, H., Andreux, P. A., Cettour-Rose, P., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.022 · Cited by 1,238
Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation
Lombard, D. B., Alt, F. W., Cheng, H.-L., Bunkenborg, J., Streeper, R. S., Mostoslavsky, R., Kim, J., Yancopoulos, G., Valenzuela, D., Murphy, A., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01636-07 · Cited by 1,216
Self-citationCardiac Metabolism in Heart Failure
Doenst, T., Nguyễn, T. D., & Abel, E. D. (2013) · Circulation Research · doi:10.1161/circresaha.113.300376 · Cited by 1,134
Mills, K. F., Yoshida, S., Stein, L. R., Grozio, A., Kubota, S., Sasaki, Y., Redpath, P., Migaud, M. E., Apte, R. S., Uchida, K., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.013 · Cited by 930
Cardiac Metabolism and its Interactions With Contraction, Growth, and Survival of Cardiomyocytes
Kolwicz, S. C., Purohit, S., & Tian, R. (2013) · Circulation Research · doi:10.1161/circresaha.113.302095 · Cited by 838
Mitochondrial function as a therapeutic target in heart failure
Brown, D. A., Perry, J. B., Allen, M. E., Sabbah, H. N., Stauffer, B. L., Shaikh, S. R., Cleland, J. G. F., Colucci, W. S., Butler, J., Voors, A. A., et al. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.203 · Cited by 829
Research works printed but not linked: 1
- 10.1016/j.celrep.2015.09.023 · DOI
Cited by
Sorted by citations
Mechanisms of physiological and pathological cardiac hypertrophy
Nakamura, M., & Sadoshima, J. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0007-y · Cited by 1,709
NAD+ metabolism and its roles in cellular processes during ageing
Covarrubias, A. J., Perrone, R., Grozio, A., & Verdin, E. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00313-x · Cited by 1,617
Cardiac Energy Metabolism in Heart Failure
Lopaschuk, G. D., Karwi, Q. G., Tian, R., Wende, A. R., & Abel, E. D. (2021) · Circulation Research · doi:10.1161/circresaha.121.318241 · Cited by 1,458
NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR
Yoshino, J., Baur, J. A., & Imai, S.-I. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.11.002 · Cited by 1,061
Mitochondrial dysfunction in pathophysiology of heart failure
Zhou, B., & Tian, R. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120849 · Cited by 973
Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence
Rajman, L., Chwalek, K., & Sinclair, D. A. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.011 · Cited by 865
Sirtuins and NAD + in the Development and Treatment of Metabolic and Cardiovascular Diseases
Kane, A. E., & Sinclair, D. A. (2018) · Circulation Research · doi:10.1161/circresaha.118.312498 · Cited by 497
Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles
Bonora, M., Wieckowski, M. R., Sinclair, D. A., Kroemer, G., Pinton, P., & Galluzzi, L. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0074-0 · Cited by 308
NAD + Metabolism in Cardiac Health, Aging, and Disease
Abdellatif, M., Sedej, S., & Kroemer, G. (2021) · Circulation · doi:10.1161/circulationaha.121.056589 · Cited by 267
NAD + Repletion Reverses Heart Failure With Preserved Ejection Fraction
Tong, D., Schiattarella, G. G., Jiang, N., Altamirano, F. J., Szweda, P. A., Elnwasany, A., Lee, D. I., Yoo, H., Kass, D. A., Szweda, L. I., et al. (2021) · Circulation Research · doi:10.1161/circresaha.120.317046 · Cited by 237
NADH Autofluorescence—A Marker on its Way to Boost Bioenergetic Research
Schaefer, P. M., Kalinina, S., Rueck, A. C., Arnim, C. A. F. V., & von Einem, B. (2018) · Cytometry Part A · doi:10.1002/cyto.a.23597 · Cited by 235
Hong, W., Mo, F., Zhang, Z., Huang, M., & Wei, X. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00246 · Cited by 182
Nicotinamide Mononucleotide: Exploration of Diverse Therapeutic Applications of a Potential Molecule
Poddar, S. K., Sifat, A. E., Haque, S., Nahid, N. A., Chowdhury, S., & Mehedi, I. (2019) · Biomolecules · doi:10.3390/biom9010034 · Cited by 134
Unlocking the Secrets of Mitochondria in the Cardiovascular System
Tian, R., Colucci, W. S., Arany, Z. P., Bachschmid, M. M., Ballinger, S. W., Boudina, S., Bruce, J. E., Busija, D. W., Dikalov, S., Dorn, G. W., et al. (2019) · Circulation · doi:10.1161/circulationaha.119.040551 · Cited by 135
NMN recruits GSH to enhance GPX4-mediated ferroptosis defense in UV irradiation induced skin injury
Feng, Z., Qin, Y., Huo, F., Jian, Z., Li, X., Geng, J., Li, Y., & Wu, J. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166287 · Cited by 123
The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update
Song, Q., Zhou, X., Xu, K., Liu, S., Zhu, X., & Yang, J. J. (2023) · Advances in Nutrition · doi:10.1016/j.advnut.2023.08.008 · Cited by 127
Yamamura, S., Izumiya, Y., Araki, S., Nakamura, T., Kimura, Y., Hanatani, S., Yamada, T., Ishida, T., Yamamoto, M., Onoue, Y., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.13357 · Cited by 121
Sirtuin 5 is required for mouse survival in response to cardiac pressure overload
Hershberger, K. A., Abraham, D., Martin, A. S., Mao, L., Liu, J., Gu, H., Locasale, J. W., & Hirschey, M. D. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.809897 · Cited by 105
Self-citationLiao, B., Zhao, Y., Wang, D., Zhang, X., Xuan-ming, H., & Hu, M. (2021) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-021-00442-4 · Cited by 106
NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis
Braidy, N., & Liu, Y. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110831 · Cited by 98
Safety and Tolerability of Nicotinamide Riboside in Heart Failure With Reduced Ejection Fraction
Wang, D. D., Airhart, S. E., Zhou, B., Shireman, L. M., Jiang, S., Rodriguez, C. M., Kirkpatrick, J. N., Shen, D. D., Tian, R., & O’Brien, K. D. (2022) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2022.06.012 · Cited by 89
Mitochondrial quality control in health and cardiovascular diseases
Atici, A. E., Crother, T. R., & Rivas, M. N. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1290046 · Cited by 85
Toward understanding genomic instability, mitochondrial dysfunction and aging
Fakouri, N. B., Hou, Y., Demarest, T. G., Christiansen, L. S., Okur, M. N., Mohanty, J. G., Croteau, D. L., & Bohr, V. A. (2019) · The FEBS Journal · doi:10.1111/febs.14663 · Cited by 77
Tannous, C., Booz, G. W., Altara, R., Muhieddine, D. H., Mericskay, M., Refaat, M. M., & Zouein, F. A. (2020) · Acta Physiologica · doi:10.1111/apha.13551 · Cited by 80
Extreme Acetylation of the Cardiac Mitochondrial Proteome Does Not Promote Heart Failure
Davidson, M. T., Grimsrud, P. A., Lai, L., Draper, J. A., Fisher‐Wellman, K. H., Narowski, T. M., Abraham, D., Koves, T. R., Kelly, D. P., & Muoio, D. M. (2020) · Circulation Research · doi:10.1161/circresaha.120.317293 · Cited by 78
Self-citationHigh Levels of Frataxin Overexpression Lead to Mitochondrial and Cardiac Toxicity in Mouse Models
Belbellaa, B., Reutenauer, L., Messaddeq, N., Monassier, L., & Puccio, H. M. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.08.018 · Cited by 78
Sanchez-Contreras, M., Sweetwyne, M. T., Tsantilas, K. A., Whitson, J. A., Campbell, M. D., Kohrn, B. F., Kim, H. J., Hipp, M. J., Fredrickson, J., Nguyen, M. M., et al. (2023) · eLife · doi:10.7554/elife.83395 · Cited by 71
Mitochondrial dysfunction in heart failure and its therapeutic implications
Liu, M., Lv, J., Pan, Z., Wang, D., Zhao, L., & Guo, X. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.945142 · Cited by 75
Emerging potential benefits of modulating NAD + metabolism in cardiovascular disease
Matasic, D. S., Brenner, C., & London, B. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00409.2017 · Cited by 63
Walker, M. A., & Tian, R. (2018) · Circulation · doi:10.1161/circulationaha.117.032626 · Cited by 63
NAD(H) in mitochondrial energy transduction: implications for health and disease
Walker, M. A., & Tian, R. (2018) · Current Opinion in Physiology · doi:10.1016/j.cophys.2018.03.011 · Cited by 59
Vignier, N., Chatzifrangkeskou, M., Rodríguez, B. M., Mericskay, M., Mougenot, N., Wahbi, K., Bonne, G., & Muchir, A. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy278 · Cited by 60
Liu, L., Xie, Y., Li, G., Zhang, T., Sui, Y., Zhao, Z., Zhang, Y., Yang, W., Geng, X., Xue, D., et al. (2023) · British Journal of Pharmacology · doi:10.1111/bph.15980 · Cited by 56
Koentges, C., Cimolai, M. C., Pfeil, K., Wolf, D., Marchini, T., Tarkhnishvili, A., Hoffmann, M. M., Odening, K. E., Diehl, P., Mühlen, C. V. Z., et al. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.06.008 · Cited by 57
Williams, A. S., Koves, T. R., Davidson, M. T., Crown, S. B., Fisher‐Wellman, K. H., Torres, M. J., Draper, J. A., Narowski, T. M., Slentz, D. H., Lantier, L., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.11.003 · Cited by 55
Self-citationPoljšak, B., Kovač, V., Špalj, S., & Milisav, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032959 · Cited by 56
Fisher‐Wellman, K. H., Draper, J. A., Davidson, M. T., Williams, A. S., Narowski, T. M., Slentz, D. H., Ilkayeva, O., Stevens, R. D., Wagner, G. R., Najjar, R. S., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.01.057 · Cited by 49
Self-citationEmerging Roles of SIRT3 in Cardiac Metabolism
Murugasamy, K., Munjal, A., & Sundaresan, N. R. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.850340 · Cited by 48
Hershberger, K. A., Abraham, D., Liu, J., Locasale, J. W., Grimsrud, P. A., & Hirschey, M. D. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002187 · Cited by 46
Self-citationOmaveloxolone: an activator of Nrf2 for the treatment of Friedreich ataxia
Profeta, V., McIntyre, K., Wells, M., Park, C. C., & Lynch, D. R. (2023) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2023.2173063 · Cited by 46
Multi-targeted Effect of Nicotinamide Mononucleotide on Brain Bioenergetic Metabolism
Klimova, N., & Kristián, T. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02729-0 · Cited by 43
Walker, M. A., Chen, H., Yadav, A. S., Ritterhoff, J., Villet, O. M., McMillen, T. S., Wang, Y., Purcell, H. J., Djukovic, D., Raftery, D., et al. (2023) · Circulation · doi:10.1161/circulationaha.123.066039 · Cited by 43
Belbellaa, B., Reutenauer, L., Monassier, L., & Puccio, H. M. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy427 · Cited by 41
Titin truncations lead to impaired cardiomyocyte autophagy and mitochondrial function in vivo
Zhou, J., Ng, B., Ko, N. S. J., Fiedler, L. R., Khin, E. S. W., Lim, A. R., Sahib, N. B. E., Wu, Y., Chothani, S. P., Schäfer, S., et al. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz033 · Cited by 40
SIRT3 is required for liver regeneration but not for the beneficial effect of nicotinamide riboside
Mukherjee, S., Mo, J., Paolella, L. M., Perry, C. E., Toth, J., Hugo, M., Chu, Q., Tong, Q., Chellappa, K., & Baur, J. A. (2021) · JCI Insight · doi:10.1172/jci.insight.147193 · Cited by 40
Caloric restriction mimetics for the treatment of cardiovascular diseases
Sciarretta, S., Forte, M., Castoldi, F., Frati, G., Versaci, F., Sadoshima, J., Kroemer, G., & Maiuri, M. C. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa297 · Cited by 39
Current Uncertainties and Future Challenges Regarding NAD+ Boosting Strategies
Poljšak, B., Kovač, V., & Milisav, I. (2022) · Antioxidants · doi:10.3390/antiox11091637 · Cited by 42
Chiang, S., Braidy, N., Maleki, S., Lal, S., Richardson, D. R., & Huang, M. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102038 · Cited by 36
Improving lysosomal ferroptosis with NMN administration protects against heart failure
Yagi, M., Do, Y., Hirai, H., Miki, K., Toshima, T., Fukahori, Y., Setoyama, D., Abe, C., Nabeshima, Y., Kang, D., et al. (2023) · Life Science Alliance · doi:10.26508/lsa.202302116 · Cited by 39
Allosteric, transcriptional and post-translational control of mitochondrial energy metabolism
Karwi, Q. G., Joerg, A. R., & Lopaschuk, G. D. (2019) · Biochemical Journal · doi:10.1042/bcj20180617 · Cited by 38
Post-translational Acetylation Control of Cardiac Energy Metabolism
Ketema, E. B., & Lopaschuk, G. D. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.723996 · Cited by 37
Role and Potential Mechanisms of Nicotinamide Mononucleotide in Aging
Rahman, S. U., Qadeer, A., & Wu, Z. (2024) · Aging and disease · doi:10.14336/ad.2023.0519-1 · Cited by 34
Ramanathan, C., Lackie, T., Williams, D. H., Simone, P. S., Zhang, Y., & Bloomer, R. J. (2022) · Nutrients · doi:10.3390/nu14020300 · Cited by 33
Luo, C., Ding, W., Yang, C., Zhang, W., Liu, X., & Deng, H. (2022) · Journal of Proteome Research · doi:10.1021/acs.jproteome.2c00167 · Cited by 33
Self-citationAgeing and longevity genes in cardiovascular diseases
Liberale, L., Kraler, S. C., Camici, G. G., & Lüscher, T. F. (2020) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13426 · Cited by 34
Xu, W., Li, L., & Zhang, L. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00901 · Cited by 35
Therapeutic Potential of Emerging NAD+-Increasing Strategies for Cardiovascular Diseases
Rotllán, N., Camacho, M., Tondo, M., Diarte‐Añazco, E. M. G., Canyelles, M., Méndez‐Lara, K. A., Benı́tez, S., Alonso, N., Mauricio, D., Escolá‐Gil, J. C., et al. (2021) · Antioxidants · doi:10.3390/antiox10121939 · Cited by 31
Sedley, L. (2020) · Epigenetics Insights · doi:10.1177/2516865720981924 · Cited by 30
Microtubules Sequester Acetylated YAP in the Cytoplasm and Inhibit Heart Regeneration
Liu, S., Deshmukh, V., Meng, F., Wang, Y., Morikawa, Y., Steimle, J. D., Li, G., Wang, J., & Martin, J. F. (2024) · Circulation · doi:10.1161/circulationaha.123.067646 · Cited by 31
NAD+ and Vascular Dysfunction: From Mechanisms to Therapeutic Opportunities
Abdellatif, M., Bugger, H., Kroemer, G., & Sedej, S. (2022) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2022.11.2.111 · Cited by 26
Wu, W., Yuan, S., Tang, Y., Meng, X., Peng, M., Hu, Z., & Liu, W. (2023) · Nutrients · doi:10.3390/nu15132851 · Cited by 33
Advances in the Synthesis and Physiological Metabolic Regulation of Nicotinamide Mononucleotide
Zheng, C., Li, Y., Wu, X., Gao, L., & Chen, X. (2024) · Nutrients · doi:10.3390/nu16142354 · Cited by 26
Advancements in NMN biotherapy and research updates in the field of digestive system diseases
Liao, G., Xie, Y., Peng, H., Li, T., Zou, X., Yue, F., Guo, J., & Rong, L. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05614-9 · Cited by 27
Sirtuins in the Cardiovascular System: Potential Targets in Pediatric Cardiology
Ianni, A., Yuan, X., Bober, E., & Braun, T. W. (2018) · Pediatric Cardiology · doi:10.1007/s00246-018-1848-1 · Cited by 27
Li, P., Newhardt, M. F., Matsuzaki, S., Eyster, C. A., Pranay, A., Peelor, F. F., Batushansky, A., Kinter, C. S., Subramani, K., SUBRAHMANIAN, S. M., et al. (2022) · GeroScience · doi:10.1007/s11357-022-00695-0 · Cited by 27
Assiri, M. A., Ali, H., Marentette, J., Yun, Y., Liu, J., Hirschey, M. D., Saba, L. M., Harris, P. S., & Fritz, K. S. (2019) · Human Genomics · doi:10.1186/s40246-019-0251-1 · Cited by 25
Self-citationBenjamin, C., & Crews, R. (2024) · Metabolites · doi:10.3390/metabo14060341 · Cited by 25
NAD metabolism and heart failure: Mechanisms and therapeutic potentials
Walker, M. A., & Tian, R. (2024) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2024.07.008 · Cited by 25
Nicotinamide Mononucleotide Administration Amends Protein Acetylome of Aged Mouse Liver
Luo, C., Ding, W., Zhu, S., Chen, Y., Liu, X., & Deng, H. (2022) · Cells · doi:10.3390/cells11101654 · Cited by 26
Self-citationNAD+-boosting molecules suppress mast cell degranulation and anaphylactic responses in mice
Kim, H.-W., Ryoo, G.-H., Jang, H., Rah, S., Lee, D. H., Kim, D., Bae, E. J., & Park, B. (2022) · Theranostics · doi:10.7150/thno.69684 · Cited by 29
Cardiovascular Research in Friedreich Ataxia
Payne, R. M. (2022) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2022.04.005 · Cited by 25
Self-citationNicotinamide Mononucleotide: Research Process in Cardiovascular Diseases
Deng, H., Ding, D., Ma, Y., Zhang, H., Wang, N., Zhang, C., & Yang, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179526 · Cited by 25
Loss of cardiac mitochondrial complex I persulfidation impairs NAD+ homeostasis in aging
Drekolia, M.-K., Karantanou, C., Wittig, I., Li, Y., Fuhrmann, D. C., Brüne, B., Katsouda, A., Hu, J., Papapetropoulos, A., & Bibli, S. (2023) · Redox Biology · doi:10.1016/j.redox.2023.103014 · Cited by 22
Sanz‐Alcázar, A., Britti, E., Delaspre, F., Medina‐Carbonero, M., Pazos-Gil, M., Tamarit, J., Ros, J., & Cabiscol, E. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-05064-4 · Cited by 21
Pathobiochemistry of Aging and Neurodegeneration: Deregulation of NAD+ Metabolism in Brain Cells
Kolotyeva, N. A., Groshkov, A. A., Rozanova, N. A., Berdnikov, A. K., Novikova, S. V., Komleva, Y. K., Salmina, A. B., Illarioshkin, S. N., & Пирадов, М. А. (2024) · Biomolecules · doi:10.3390/biom14121556 · Cited by 24
Cellular pathophysiology of Friedreich's ataxia cardiomyopathy
Lees, J. G., Напиерала, М., Pébay, A., Dottori, M., & Lim, S. Y. (2021) · International Journal of Cardiology · doi:10.1016/j.ijcard.2021.11.033 · Cited by 20
Wang, L., Peng, T., Deng, J., Gao, W., Wang, H., Luo, O. J., Huang, L., & Chen, G. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116272 · Cited by 19
Fan, Y., Zhao, H., Lu, L., & Wu, W. (2025) · Nutrients · doi:10.3390/nu17111855 · Cited by 21
Metabolite signaling in the heart
Flam, E. L., & Arany, Z. P. (2023) · Nature Cardiovascular Research · doi:10.1038/s44161-023-00270-6 · Cited by 19
Safety Evaluation for Restorin® NMN, a NAD+ Precursor
Turner, J. R., Licollari, A., Mihalcea, E., & Tan, A. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.749727 · Cited by 19
NAD supplementation improves mitochondrial performance of cardiolipin mutants
Ji, J., Damschroder, D., Bessert, D. A., Lazcano, P., Wessells, R. J., Reynolds, C. A., & Greenberg, M. L. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.159094 · Cited by 17
Vásquez-Trincado, C., Patel, M., Sivaramakrishnan, A., Bekeová, C., Anderson‐Pullinger, L., Wang, N., Tang, H., & Seifert, E. L. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab216 · Cited by 14
Omoto, A. C. M., do Carmo, J. M., Nelson, B. J., Aitken, N. M., Dai, X., Moak, S. P., Flynn, E., Wang, Z., Mouton, A. J., Li, X., et al. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.027081 · Cited by 13
Liang, J., Zhou, C., Zhang, C., Liang, S., Zhou, Z., Zhou, Z., Wu, C., Zhao, H., Meng, X., Zou, F., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111328 · Cited by 14
Drug Repositioning in Friedreich Ataxia
Rufini, A., Malisan, F., Condò, I., & Testi, R. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.814445 · Cited by 14
Hall, A. R., Karwi, Q. G., Kumar, S., Dongworth, R. K., Aksentijević, D., Altamimi, T., Fridianto, K. T., Chinda, K., Hernández‐Reséndiz, S., Mahmood, M. U., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-23847-w · Cited by 13
NAD+ metabolism and retinal degeneration (Review)
Pîrvu, A. S., Andrei, A. M., Stănciulescu, E. C., Baniţă, I. M., Pisoschi, C. G., Jurja, S., & Ciuluvica, R. C. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10102 · Cited by 12
Nicotinamide mononucleotide: An emerging nutraceutical against cardiac aging?
Wei, Z., Chai, H., Chen, Y., Cheng, Y., & Liu, X. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.08.006 · Cited by 13
Self-citationBiosynthesis of β-nicotinamide mononucleotide from glucose via a new pathway in Bacillus subtilis
Tan, Z., Yang, Y., Wu, Y., Yan, J., Zhang, B., Hou, Y., & Jia, S. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1405736 · Cited by 11
NAD in pathological cardiac remodeling: Metabolic regulation and beyond
Norambuena‐Soto, I., Deng, Y., Brenner, C., Lavandero, S., & Wang, Z. V. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167038 · Cited by 9
Hyperactivation of mTOR and AKT in a cardiac hypertrophy animal model of Friedreich ataxia
Tong, W.-H., Ollivierre, H., Noguchi, A. C., Ghosh, M. C., Springer, D., & Rouault, T. A. (2021) · Heliyon · doi:10.1016/j.heliyon.2022.e10371 · Cited by 9
Metabolomics analysis reveals dysregulation in one carbon metabolism in Friedreich Ataxia
O’Connell, T. M., Logsdon, D. L., & Payne, R. M. (2022) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2022.06.002 · Cited by 9
Self-citationAlashti, F. A., & Goliaei, B. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177651 · Cited by 8
Expanding the landscape of lysine acetylation stoichiometry and clinical impact
Encarnación‐Guevara, S., & Gil, J. (2025) · Journal of Proteomics · doi:10.1016/j.jprot.2025.105522 · Cited by 10
Kourek, C., Briasoulis, Α., Papamichail, A., Xanthopoulos, A. V., Tsougos, E., Farmakis, D. T., & PARASKEVAIDIS, I. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063113 · Cited by 11
Yang, S., Jing, S., Wang, S., & Jia, F. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1303645 · Cited by 7
Zhang, Y., Long, X., Yao, B.-F., Tian, J., Peng, J., & Luo, X. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.09.026 · Cited by 6
Liu, S., Deshmukh, V., Wang, F., Liang, J., Cusick, J., Li, X., & Martin, J. F. (2024) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2024.02.014 · Cited by 6
NAD+ enhancers as therapeutic agents in the cardiorenal axis
Marin-Blazquez, M., Rovira, J., Ramírez-Bajo, M. J., Perez, R. Z., & Rabadán-Ros, R. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01903-4 · Cited by 7
Controversial Impact of Sirtuins in Chronic Non-Transmissible Diseases and Rehabilitation Medicine
Mongelli, A., & Gaetano, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103080 · Cited by 6
Metadata
- Authors
- Martin, A. S., Abraham, D. M., Hershberger, K. A., Bhatt, D. P., Mao, L., Cui, H., Liu, J., Liu, X., Muehlbauer, M. J., Grimsrud, P. A., Locasale, J. W., Payne, R. M., & Hirschey, M. D.
- Affiliations
- Duke University (US)
- Department of Pharmacology and Cancer Biology,
- Indiana University Indianapolis (US)
- ORCID
- Venue
- JCI Insight
- Published
- 2017-07-20
- Volume
- 2
- Issue
- 14
- ISSN
- 2379-3708 (ISSN-L)
- PMC
- PMC5518566
- OpenAlex
- W2736952832
- Cited by
- 128
- References
- 69
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 16 · 2023: 17 · 2022: 22 · 2021: 18 · 2020: 11 · 2019: 11 · 2018: 15 · 2017: 3
- FWCI
- 6.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- JCI Insight (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Heart Association
- Friedreich's Ataxia Research Alliance
- National Institutes of Health
- National Institute on Alcohol Abuse and Alcoholism (R01AA022146)
- National Heart, Lung, and Blood Institute (F31HL123275, K08HL125905)
- National Cancer Institute (R00CA168997)
- National Institute of General Medical Sciences (T32GM007184, T32GM007105)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK096493)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- nicotinamide mononucleotide, SIRT3, cardiac function, myocardial energy metabolism, mitochondrial metabolism, NAD+ supplementation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review